CLINICAL_TRIALS
trial_result
· 2011-04-19
Clinical Trial Update: Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1% [Phase 3]
Summary
Phase 3 trial evaluating the efficacy and safety of adapalene 0.1% for acne vulgaris has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Galderma R&D | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2011-04-19